Story
Ford Halts F-150 Production at Key Michigan Plant, Memo Shows
Summary
Ford Motor has suspended production of its highly profitable F-150 pickup truck at its Dearborn Truck Plant for nearly a week, with related disruptions reported at another facility, according to a company memo.
Ford Motor (NYSE: F) has halted production of its flagship F-150 pickup truck at a key Detroit-area plant for nearly a week, according to an internal memo viewed by Reuters. The stoppage affects one of the automaker's most important and profitable vehicle lines.
Details of the Stoppage
The memo states that all production crews at the Dearborn Truck Plant were canceled from Thursday through Tuesday, September 29. The reason for the production halt was not specified in the report.
The disruption extends beyond the single plant. Ford’s Kansas City Assembly Plant also canceled some shifts this week due to the same unspecified issue impacting the Dearborn facility, a person familiar with the matter told Reuters.
AdMarket Impact and Response
The F-150 is a cornerstone of Ford's revenue and profitability, and any significant production interruption can have a direct impact on the company's quarterly financial results. The F-Series trucks are consistently among the best-selling vehicles in the United States, making their production volume critical for investors to watch.
To mitigate the shortfall, Ford is reportedly increasing F-150 output at its Kentucky Truck Plant near Louisville, according to the same source. This move aims to compensate for the production losses at the Dearborn and Kansas City locations.
Read next
More on Stocks
Viavi Solutions Stock Jumps on Key Department of Defense Cybersecurity Certification
Shares of the network testing and measurement company gained more than 6% after its Aerospace and Defense division secured a critical certification required for U.S. defense contracts.
Oslo OBX Index Falls to One-Month Low as Energy Stocks Decline
Norway's benchmark Oslo OBX index closed down 0.79% on Friday, reaching a new one-month low, as declines in energy and industrial shares outweighed gains in the seafood sector.
B. Riley Highlights Biotech Opportunities as Rate Hikes Pressure Sector
An analyst at B. Riley has identified several biotech stocks poised for growth ahead of Q3 earnings, suggesting that recent market drawdowns driven by Federal Reserve rate hikes have created attractive entry points for investors. The firm points to strong company-specific catalysts and improving sector fundamentals despite the challenging macroeconomic environment.
Viavi Solutions Options See Surge in Bullish Bets on Breakout Above $40
Unusually heavy call option volume in Viavi Solutions (VIAV) suggests traders are betting on a near-term move above $40, fueled by a key cybersecurity certification for its defense division.